Navigation Links
Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
Date:6/30/2011

VA149; the combination of NVA237 with Novartis' once-daily, long-acting beta2-agonist (LABA), indacaterol, is planned for 2013.  Indacaterol is now approved in more than 50 countries and available in more than 20, with US approval dependent on an FDA decision expected in July 2011. 

Notes for Editors:

About COPD

COPD is a chronic obstruction of the airways which affects 210 million people worldwide[1] and is projected to be the third leading cause of death by 2020[2].  It is a progressive lung disease with symptoms including chronic bronchitis and/or emphysema, which slowly progresses and eventually leads to a largely irreversible loss of lung function.  While there is no cure, bronchodilators such as LAMAs and LABAs make breathing easier by enlarging the patient's airways, and are recognised in international guidelines as an integral part of the treatment for COPD.

About Sosei

Sosei is an international biopharmaceutical company anchored in Japan with a global reach. It practises a reduced risk business model by acquiring compounds from, and bringing compounds into, Japan through exploitation of its unique position within global markets.

For further information about Sosei, please visit http://www.sosei.com/.

Forward-Looking Statements

This press release contains "forward-looking statements", including statements about the discovery, development and commercialisation of products. Various risks may cause Sosei's actual results to differ materially from those expressed or implied by the forward-looking statements, including adverse results in clinical development programmes; failure to obtain patent protection for inventions; commercial limitations imposed by patents owned or controlled by third parties; dependence upon strategic alliance partners to develop and commercialise products and serv
'/>"/>

SOURCE Sosei Group Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
2. Phase I of the Swedish/Issaquah Medical Center Campus to Open in July
3. The Lancet Publishes Data from Protege, MacroGenics Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
4. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
5. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
6. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
7. Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101
8. Ampio Pharmaceuticals, Inc. Releases Results From Phase III Clinical Trial of Zertane™ for the Treatment of Premature Ejaculation (PE), the Most Prevalent Form of Male Sexual Dysfunction
9. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
10. Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011
11. New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  When Ryan ... the side of his neck, he figured ... a couple weeks off from weight lifting. ... away.                               A series ... was referred to Michel Kliot, MD ...
(Date:5/21/2015)... CITY, Calif. , May 21, 2015  Cardica, Inc. ... 2015, new employee Greg Watson , the company,s vice ... shares of the company,s common stock, at a per share ... 20, 2015. The stock option was granted pursuant to Cardica, ... of directors in May 2015 under Rule 5653(c)(4) of the ...
(Date:5/21/2015)... 2015  Heidrick & Struggles (Nasdaq: HSII ), ... leadership consulting and culture shaping worldwide, ... practices announcing the addition of Tim Dietlin ... Dietlin has extensive life sciences and ... R&D, Medical and Commercial functions to increase productivity, drive ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4Cardica Announces New Employment Inducement Grant 2Heidrick Increases Healthcare and Life Sciences Expertise 2
... Orthopaedic Associates (AOA) in Largo, FL, has chosen to ... White Plume Technologies between Exscribe electronic health record ... system (PM system). EMRs can be powerful ... unfilled. White Plume Technologies bridges EMR gaps by ...
... DIA and the National Pharmaceutical Council (NPC) will ... Guide  Conference on March 14-15 at the Renaissance ... focus on the continued push for increased levels ... within health technology assessments, research planning and drug ...
Cached Medicine Technology:Alexander Orthopaedic Associates Chooses White Plume Technologies to Fill the EMR Gap 2DIA and National Pharmaceutical Council Will Host Two-Day Conference on Comparative Effectiveness Research 2
(Date:5/22/2015)... May 22, 2015 sweetFrog Enterprises, LLC. is ... Jacksonville, Texas. Jacksonville is now the 16th sweetFrog store located ... was listed as #22 on the Inc. 500 list of ... lived and worked in East Texas for 20 years and ... owner of the Jacksonville, and nearby Palestine, sweetFrog locations. “We ...
(Date:5/22/2015)... Wimbledon Health Partners, the leading on-site diagnostic ... NCV testing , is proud to announce the ... National athlete, to the Wimbledon Athletics division. , ... of testing and information it provides to be extremely ... this way they can focus on the task at ...
(Date:5/22/2015)... 22, 2015 Ticket Down is a reputable ... Rangers NHL Eastern Conference Finals Tickets . All seating ... otherwise in the ticket listing. , For the first ... the top of the Eastern Conference. One of the original ... of ups and downs over the years, but the excitement ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Steven Winter ... Marc Zuluaga, has been selected by Consulting-Specifying Engineer (CSE) ... award winners are featured in the May/June issue of ... building industry professionals age 40 and younger who have, ... community, as well as in other areas of their ...
(Date:5/22/2015)... Chicago, IL (PRWEB) May 22, 2015 Co ... whose purpose is to allow general dentists to immediately deliver ... concept is based on that of the medical surgeon. ... addresses six main roadblocks preventing general dentists from placing dental ... taking the necessary steps to introduce the surgical placement of ...
Breaking Medicine News(10 mins):Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2
... smuggled into the United States was found in a Detroit-area ... Michigan health// officials have been trying to trace its source. ... that the frozen poultry, some even packed with entrails intact, ... ,State officials, however has said that no testing for ...
... United States (where Ariz., N.M., Colo. and Utah meet) will ... in 2005//, say scientists at Johns Hopkins University, the University ... that parts of southern Colo. and north-central N.M.--previously at low-risk ... risk in 2006. ,The study is among the ...
... cord dysfunction (VCD) – an involuntary functional disorder during ... a long-term study published in the current issue of ... of the American College of Allergy, Asthma and Immunology ... Pulmonary Division at the University of Iowa College of ...
... a new source of adult stem cells, which have the ... cells show no allergic reactions in human and animal studies ... to meet the needs of an individual to treat a ... and spinal cord injury. ,"We are very excited ...
... UK government has planned to outlaw sex selection of babies ... regulation.// ,Health Minister Caroline Flint has told Parliament ... on the use of techniques to choose a gender of ... be the start of a "slippery slope" to designer babies. ...
... of Appeal has passed a ruling on the provision of ... ,According to Mary Anne Chambers, Ontario's Minister of Children ... this would spell for the families of autistic children, the ... to provide support and services to autistic children regardless of ...
Cached Medicine News:Health News:Increased Risk of Hantavirus Forecast for U.S. Southwest 2Health News:Two Distinct Types of Vocal Cord Dysfunction Identified 2Health News:Varied Applications of Adult Stem Cells to Treat Host of Disorders in Human 2Health News:Ontario Continues Support for Autistic Children 2
Sealing tape, slightly stiffer than Polyolefin tape....
Sealing tape, slightly stiffer than Polyolefin tape. Certified RNase and DNase free....
Empore Sealing Tape Pads are ideal for covering a 96 well plate during storage or transfer to another work station. Not intended for use with auto-injectors....
Mylar Plate Sealers 100/Box...
Medicine Products: